Long-term safety and efficacy of imatinib in pulmonary arterial hypertension

被引:0
|
作者
Hoeper, Marius [1 ]
Barst, Robyn [2 ]
Galie, Nazzareno [3 ]
Hassoun, Paul [4 ]
Morrell, Nicholas [5 ,6 ]
Peacock, Andrew [7 ]
Simonneau, Gerald [8 ]
Tapson, Victor [9 ]
Torres, Fernando [10 ]
Lawrence, David [11 ]
Quinn, Deborah [12 ]
Ghofrani, Hossein Ardeschir [13 ]
机构
[1] Med Hsch, Resp Med, Hannover, Germany
[2] Columbia Univ, Resp Med, New York, NY USA
[3] Azienda Osped Univ Bologna, Resp Med, Bologna, Italy
[4] Johns Hopkins Univ, Resp Med, Baltimore, MD USA
[5] Addenbrookes Hosp, Resp Med, Cambridge, England
[6] Papworth Hosp, Resp Med, Cambridge, England
[7] Golden Jubilee Natl Hosp, Resp Med, Glasgow, Lanark, Scotland
[8] Univ Paris Sud XI, Resp Med, Orsay, France
[9] Duke Univ, Med Ctr, Resp Med, Durham, NC USA
[10] UT Southwestern Med Ctr, Resp Med, Dallas, TX USA
[11] Novartis Horsham Res Ctr, Resp Med, Horsham, W Sussex, England
[12] Novartis Pharmaceut, Resp Med, Cambridge, MA USA
[13] Univ Hosp Giessen & Marburg GmbH, Resp Med, Giessen, Germany
关键词
Pulmonary hypertension; Treatments;
D O I
暂无
中图分类号
R56 [呼吸系及胸部疾病];
学科分类号
摘要
3488
引用
收藏
页数:2
相关论文
共 50 条
  • [21] Evaluating the safety and long-term efficacy of triple vasodilator therapy for pulmonary arterial hypertension associated with congenital heart disease
    Luna, R.
    Segura De La Cal, T.
    Salguero, R.
    Arribas, F.
    Escribano Subias, P.
    Sarnago Cebada, F.
    EUROPEAN HEART JOURNAL, 2023, 44
  • [22] PULSAR Open-Label Extension: Long-Term Efficacy and Safety of Sotatercept for the Treatment of Pulmonary Arterial Hypertension (PAH)
    Humbert, M.
    Mclaughlin, V. V.
    Gibbs, S. R.
    Gomberg-Maitland, M.
    Hoeper, M.
    Preston, I. R.
    Souza, R.
    Waxman, A. B.
    Ghofrani, H. A.
    Subias, P. Escribano
    Feldman, J. P.
    Bohns Meyer, G.
    Montani, D.
    Olsson, K. M.
    Manimaran, S.
    Pena, J. de Oliveira
    Badesch, D. B.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2022, 205
  • [23] Long-Term Pulmonary Hemodynamic Effects of Ambrisentan in Pulmonary Arterial Hypertension
    Klinger, James R.
    Oudiz, Ronald J.
    Spence, Rebecca
    Despain, Darrin
    Dufton, Christopher
    AMERICAN JOURNAL OF CARDIOLOGY, 2011, 108 (02): : 302 - 307
  • [24] LONG-TERM EFFICACY AND SAFETY OF MOEXIPRIL IN THE TREATMENT OF HYPERTENSION
    WHITE, WB
    FOX, AAL
    STIMPEL, M
    JOURNAL OF HUMAN HYPERTENSION, 1994, 8 (12) : 917 - 921
  • [25] LONG-TERM EFFICACY AND SAFETY OF PRAZOSIN IN ESSENTIAL HYPERTENSION
    OKUN, R
    POSTGRADUATE MEDICINE, 1975, : 63 - 67
  • [26] LONG-TERM EFFICACY AND SAFETY OF LABETALOL IN THE TREATMENT OF HYPERTENSION
    MICHELSON, EL
    FRISHMAN, WH
    SAWIN, HS
    SABOL, SA
    LONG, CA
    POLAND, M
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1983, 1 (02) : 611 - 611
  • [27] Efficacy and safety of long-term imatinib therapy for patients with pulmonary veno-occlusive disease and pulmonary capillary hemangiomatosis
    Ogawa, Aiko
    Miyaji, Katsumasa
    Matsubara, Hiromi
    RESPIRATORY MEDICINE, 2017, 131 : 215 - 219
  • [28] Efficacy and Safety of Long-Term Oral Bosentan in Different Types of Pulmonary Arterial Hypertension: A Systematic Review and Meta-Analysis
    Kuang, Hong-yu
    Li, Qiang
    Du, Hua-an
    Chen, Min
    Yin, Yue-hui
    AMERICAN JOURNAL OF CARDIOVASCULAR DRUGS, 2021, 21 (02) : 181 - 191
  • [29] Efficacy and Safety of Long-Term Oral Bosentan in Different Types of Pulmonary Arterial Hypertension: A Systematic Review and Meta-Analysis
    Hong-yu Kuang
    Qiang Li
    Hua-an Du
    Min Chen
    Yue-hui Yin
    American Journal of Cardiovascular Drugs, 2021, 21 : 181 - 191
  • [30] Long-term sitaxsentan therapy in Pulmonary Arterial Hypertension (PAH)
    Horn, E
    Langleben, D
    Frost, A
    Hill, N
    McLaughlin, V
    Oudiz, R
    Dixon, RAF
    Barst, RJ
    EUROPEAN HEART JOURNAL, 2004, 25 : 466 - 466